Taiwan FDA registration 266d38571fc1f385891b75fa79d8b11d
"Baiyou" synthetic cell and tissue culture media and ingredients (unsterilized)
TW: "百優" 合成細胞和組織培養基及成份 (未滅菌)
Taiwan·Risk Class 1·Shiji Biomedical Co., Ltd. Taipei Plant·Registered Oct 19, 2020 – Oct 19, 2025ExpiredRegistration details
- Analysis ID
- 266d38571fc1f385891b75fa79d8b11d
Company information
- Manufacturer
- Shiji Biomedical Co., Ltd. Taipei Plant
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- BIOMAB, INC.
Product details
- Intended Use
- It is limited to the first level of identification of synthetic cell and tissue culture media and ingredients (B.2220) in the classification and grading management measures for medical devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.2220 Synthetic cell and tissue culture media and components
- Import Information
- Contract manufacturing;; Domestic
Dates and status
- Registration Date
- Oct 19, 2020
- Expiry Date
- Oct 19, 2025
About this record
Access comprehensive regulatory information for "Baiyou" synthetic cell and tissue culture media and ingredients (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 266d38571fc1f385891b75fa79d8b11d and manufactured by Shiji Biomedical Co., Ltd. Taipei Plant. The authorized representative in Taiwan is BIOMAB, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices